Biotechnology (13) | Financing Agreements (13)

Browse by Company

Athenex, Inc. (1 contract)
Biohaven Pharmaceutical Holding Co Ltd. (2)
Clovis Oncology, Inc. (2)
Environmental Impact Acquisition Corp (1)
Intrinsic Medicine, Inc. (1)
Karyopharm Therapeutics Inc. (1)
PREMIER BIOMEDICAL INC (1)
REXAHN PHARMACEUTICALS, INC. (2)
Sunshine Biopharma, Inc (1)
WINDTREE THERAPEUTICS INC (1)

Recent Contracts

Secured Superpriority Debtor-In-Possession Financing Agreement, dated as of January 6, 2023, by and among the Company, as borrower, Clovis Ireland and Clovis UK, as guarantors,... (Clovis Oncology, Inc., Filed With SEC on January 12, 2023)
Omnibus Amendment #1 to Financing Agreements by and between the Registrant and the investor who is a signatory thereto (Intrinsic Medicine, Inc., Filed With SEC on April 8, 2022)
Amendment No. 4 to Financing Agreement, dated as of December 28, 2021, by and between Biohaven Pharmaceuticals Holding Company Ltd., Biohaven Pharmaceuticals, Inc., the guarantors... (Biohaven Pharmaceutical Holding Co Ltd., Filed With SEC on February 25, 2022)
Amendment No. 3 and Limited Consent to Financing Agreement, dated November 9, 2021, by and between Biohaven Pharmaceuticals Holding Company Ltd., Biohaven Pharmaceuticals, Inc.,... (Biohaven Pharmaceutical Holding Co Ltd., Filed With SEC on November 12, 2021)
Master Equipment Financing Agreement, dated March 29, 2021, by and between Trinity Capital Inc. and GreenLight Biosciences, Inc (Environmental Impact Acquisition Corp, Filed With SEC on September 7, 2021)
Project Financing Agreement, dated August 12, 2020, by and between Windtree and Lees Pharmaceutical (HK) Ltd (WINDTREE THERAPEUTICS INC, Filed With SEC on November 16, 2020)
Financing Agreement with RB Capital Partners, Inc (Sunshine Biopharma, Inc, Filed With SEC on September 15, 2020)
Revenue Interest Financing Agreement (Athenex, Inc., Filed With SEC on August 6, 2020)
Form of Financing Lock-Up Agreement, by and among Rexahn, Ocuphire, and the investors party thereto (REXAHN PHARMACEUTICALS, INC., Filed With SEC on July 1, 2020)
Form of Financing Lock-Up Agreement, by and among Rexahn, Ocuphire, and the investors party thereto (REXAHN PHARMACEUTICALS, INC., Filed With SEC on June 19, 2020)